Association between Birth Defects and Cancer Risk among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births

Philip J. Lupo, Jeremy M. Schraw, Tania A. Desrosiers, Wendy N. Nembhard, Peter H. Langlois, Mark A. Canfield, Glenn Copeland, Robert E. Meyer, Austin L. Brown, Tiffany M. Chambers, Pagna Sok, Heather E. Danysh, Susan E. Carozza, Saumya D. Sisoudiya, Susan G. Hilsenbeck, Amanda E. Janitz, Matthew E. Oster, Angela E. Scheuerle, Joshua D. Schiffman, Chunqiao LuoAmir Mian, Beth A. Mueller, Chad D. Huff, Sonja A. Rasmussen, Michael E. Scheurer, Sharon E. Plon

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Importance: Birth defects affect approximately 1 in 33 children. Some birth defects are known to be strongly associated with childhood cancer (eg, trisomy 21 and acute leukemia). However, comprehensive evaluations of childhood cancer risk in those with birth defects have been limited in previous studies by insufficient sample sizes. Objectives: To identify specific birth defect-childhood cancer (BD-CC) associations and characterize cancer risk in children by increasing number of nonchromosomal birth defects. Design, Setting, and Participants: This multistate, population-based registry linkage study pooled statewide data on births, birth defects, and cancer from Texas, Arkansas, Michigan, and North Carolina on 10181074 children born from January 1, 1992, to December 31, 2013. Children were followed up to 18 years of age for a diagnosis of cancer. Data were retrieved between September 26, 2016, and September 21, 2017, and data analysis was performed from September 2, 2017, to March 21, 2019. Exposures: Birth defects diagnoses (chromosomal anomalies and nonchromosomal birth defects) recorded by statewide, population-based birth defects registries. Main Outcomes and Measures: Cancer diagnosis before age 18 years, as recorded in state cancer registries. Cox regression models were used to generate hazard ratios (HRs) and 95% CIs to evaluate BD-CC associations and the association between number of nonchromosomal defects and cancer risk. Results: Compared with children without any birth defects, children with chromosomal anomalies were 11.6 (95% CI, 10.4-12.9) times more likely to be diagnosed with cancer, whereas children with nonchromosomal birth defects were 2.5 (95% CI, 2.4-2.6) times more likely to be diagnosed with cancer before 18 years of age. An increasing number of nonchromosomal birth defects was associated with a corresponding increase in the risk of cancer. Children with 4 or more major birth defects were 5.9 (95% CI, 5.3-6.4) times more likely to be diagnosed with cancer compared with those without a birth defect. In the analysis of 72 specific BD-CC patterns, 40 HRs were statistically significant (adjusted P <.05) after accounting for multiple comparisons. Cancers most frequently associated with nonchromosomal defects were hepatoblastoma and neuroblastoma. Conclusions and Relevance: Several significant and novel associations were observed between specific birth defects and cancers. Among children with nonchromosomal birth defects, the number of major birth defects diagnosed was significantly and directly associated with cancer risk. These findings could inform clinical treatment for children with birth defects and may elucidate mechanisms that lead to these complex outcomes.

Original languageEnglish (US)
Pages (from-to)1150-1158
Number of pages9
JournalJAMA Oncology
Volume5
Issue number8
DOIs
StatePublished - Aug 2019

Fingerprint

Live Birth
Population
Neoplasms
Registries
Hepatoblastoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Lupo, P. J., Schraw, J. M., Desrosiers, T. A., Nembhard, W. N., Langlois, P. H., Canfield, M. A., ... Plon, S. E. (2019). Association between Birth Defects and Cancer Risk among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births. JAMA Oncology, 5(8), 1150-1158. https://doi.org/10.1001/jamaoncol.2019.1215

Association between Birth Defects and Cancer Risk among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births. / Lupo, Philip J.; Schraw, Jeremy M.; Desrosiers, Tania A.; Nembhard, Wendy N.; Langlois, Peter H.; Canfield, Mark A.; Copeland, Glenn; Meyer, Robert E.; Brown, Austin L.; Chambers, Tiffany M.; Sok, Pagna; Danysh, Heather E.; Carozza, Susan E.; Sisoudiya, Saumya D.; Hilsenbeck, Susan G.; Janitz, Amanda E.; Oster, Matthew E.; Scheuerle, Angela E.; Schiffman, Joshua D.; Luo, Chunqiao; Mian, Amir; Mueller, Beth A.; Huff, Chad D.; Rasmussen, Sonja A.; Scheurer, Michael E.; Plon, Sharon E.

In: JAMA Oncology, Vol. 5, No. 8, 08.2019, p. 1150-1158.

Research output: Contribution to journalArticle

Lupo, PJ, Schraw, JM, Desrosiers, TA, Nembhard, WN, Langlois, PH, Canfield, MA, Copeland, G, Meyer, RE, Brown, AL, Chambers, TM, Sok, P, Danysh, HE, Carozza, SE, Sisoudiya, SD, Hilsenbeck, SG, Janitz, AE, Oster, ME, Scheuerle, AE, Schiffman, JD, Luo, C, Mian, A, Mueller, BA, Huff, CD, Rasmussen, SA, Scheurer, ME & Plon, SE 2019, 'Association between Birth Defects and Cancer Risk among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births', JAMA Oncology, vol. 5, no. 8, pp. 1150-1158. https://doi.org/10.1001/jamaoncol.2019.1215
Lupo, Philip J. ; Schraw, Jeremy M. ; Desrosiers, Tania A. ; Nembhard, Wendy N. ; Langlois, Peter H. ; Canfield, Mark A. ; Copeland, Glenn ; Meyer, Robert E. ; Brown, Austin L. ; Chambers, Tiffany M. ; Sok, Pagna ; Danysh, Heather E. ; Carozza, Susan E. ; Sisoudiya, Saumya D. ; Hilsenbeck, Susan G. ; Janitz, Amanda E. ; Oster, Matthew E. ; Scheuerle, Angela E. ; Schiffman, Joshua D. ; Luo, Chunqiao ; Mian, Amir ; Mueller, Beth A. ; Huff, Chad D. ; Rasmussen, Sonja A. ; Scheurer, Michael E. ; Plon, Sharon E. / Association between Birth Defects and Cancer Risk among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births. In: JAMA Oncology. 2019 ; Vol. 5, No. 8. pp. 1150-1158.
@article{47453fd89dd240cab56e382c7353f9bd,
title = "Association between Birth Defects and Cancer Risk among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births",
abstract = "Importance: Birth defects affect approximately 1 in 33 children. Some birth defects are known to be strongly associated with childhood cancer (eg, trisomy 21 and acute leukemia). However, comprehensive evaluations of childhood cancer risk in those with birth defects have been limited in previous studies by insufficient sample sizes. Objectives: To identify specific birth defect-childhood cancer (BD-CC) associations and characterize cancer risk in children by increasing number of nonchromosomal birth defects. Design, Setting, and Participants: This multistate, population-based registry linkage study pooled statewide data on births, birth defects, and cancer from Texas, Arkansas, Michigan, and North Carolina on 10181074 children born from January 1, 1992, to December 31, 2013. Children were followed up to 18 years of age for a diagnosis of cancer. Data were retrieved between September 26, 2016, and September 21, 2017, and data analysis was performed from September 2, 2017, to March 21, 2019. Exposures: Birth defects diagnoses (chromosomal anomalies and nonchromosomal birth defects) recorded by statewide, population-based birth defects registries. Main Outcomes and Measures: Cancer diagnosis before age 18 years, as recorded in state cancer registries. Cox regression models were used to generate hazard ratios (HRs) and 95{\%} CIs to evaluate BD-CC associations and the association between number of nonchromosomal defects and cancer risk. Results: Compared with children without any birth defects, children with chromosomal anomalies were 11.6 (95{\%} CI, 10.4-12.9) times more likely to be diagnosed with cancer, whereas children with nonchromosomal birth defects were 2.5 (95{\%} CI, 2.4-2.6) times more likely to be diagnosed with cancer before 18 years of age. An increasing number of nonchromosomal birth defects was associated with a corresponding increase in the risk of cancer. Children with 4 or more major birth defects were 5.9 (95{\%} CI, 5.3-6.4) times more likely to be diagnosed with cancer compared with those without a birth defect. In the analysis of 72 specific BD-CC patterns, 40 HRs were statistically significant (adjusted P <.05) after accounting for multiple comparisons. Cancers most frequently associated with nonchromosomal defects were hepatoblastoma and neuroblastoma. Conclusions and Relevance: Several significant and novel associations were observed between specific birth defects and cancers. Among children with nonchromosomal birth defects, the number of major birth defects diagnosed was significantly and directly associated with cancer risk. These findings could inform clinical treatment for children with birth defects and may elucidate mechanisms that lead to these complex outcomes.",
author = "Lupo, {Philip J.} and Schraw, {Jeremy M.} and Desrosiers, {Tania A.} and Nembhard, {Wendy N.} and Langlois, {Peter H.} and Canfield, {Mark A.} and Glenn Copeland and Meyer, {Robert E.} and Brown, {Austin L.} and Chambers, {Tiffany M.} and Pagna Sok and Danysh, {Heather E.} and Carozza, {Susan E.} and Sisoudiya, {Saumya D.} and Hilsenbeck, {Susan G.} and Janitz, {Amanda E.} and Oster, {Matthew E.} and Scheuerle, {Angela E.} and Schiffman, {Joshua D.} and Chunqiao Luo and Amir Mian and Mueller, {Beth A.} and Huff, {Chad D.} and Rasmussen, {Sonja A.} and Scheurer, {Michael E.} and Plon, {Sharon E.}",
year = "2019",
month = "8",
doi = "10.1001/jamaoncol.2019.1215",
language = "English (US)",
volume = "5",
pages = "1150--1158",
journal = "JAMA oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - Association between Birth Defects and Cancer Risk among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births

AU - Lupo, Philip J.

AU - Schraw, Jeremy M.

AU - Desrosiers, Tania A.

AU - Nembhard, Wendy N.

AU - Langlois, Peter H.

AU - Canfield, Mark A.

AU - Copeland, Glenn

AU - Meyer, Robert E.

AU - Brown, Austin L.

AU - Chambers, Tiffany M.

AU - Sok, Pagna

AU - Danysh, Heather E.

AU - Carozza, Susan E.

AU - Sisoudiya, Saumya D.

AU - Hilsenbeck, Susan G.

AU - Janitz, Amanda E.

AU - Oster, Matthew E.

AU - Scheuerle, Angela E.

AU - Schiffman, Joshua D.

AU - Luo, Chunqiao

AU - Mian, Amir

AU - Mueller, Beth A.

AU - Huff, Chad D.

AU - Rasmussen, Sonja A.

AU - Scheurer, Michael E.

AU - Plon, Sharon E.

PY - 2019/8

Y1 - 2019/8

N2 - Importance: Birth defects affect approximately 1 in 33 children. Some birth defects are known to be strongly associated with childhood cancer (eg, trisomy 21 and acute leukemia). However, comprehensive evaluations of childhood cancer risk in those with birth defects have been limited in previous studies by insufficient sample sizes. Objectives: To identify specific birth defect-childhood cancer (BD-CC) associations and characterize cancer risk in children by increasing number of nonchromosomal birth defects. Design, Setting, and Participants: This multistate, population-based registry linkage study pooled statewide data on births, birth defects, and cancer from Texas, Arkansas, Michigan, and North Carolina on 10181074 children born from January 1, 1992, to December 31, 2013. Children were followed up to 18 years of age for a diagnosis of cancer. Data were retrieved between September 26, 2016, and September 21, 2017, and data analysis was performed from September 2, 2017, to March 21, 2019. Exposures: Birth defects diagnoses (chromosomal anomalies and nonchromosomal birth defects) recorded by statewide, population-based birth defects registries. Main Outcomes and Measures: Cancer diagnosis before age 18 years, as recorded in state cancer registries. Cox regression models were used to generate hazard ratios (HRs) and 95% CIs to evaluate BD-CC associations and the association between number of nonchromosomal defects and cancer risk. Results: Compared with children without any birth defects, children with chromosomal anomalies were 11.6 (95% CI, 10.4-12.9) times more likely to be diagnosed with cancer, whereas children with nonchromosomal birth defects were 2.5 (95% CI, 2.4-2.6) times more likely to be diagnosed with cancer before 18 years of age. An increasing number of nonchromosomal birth defects was associated with a corresponding increase in the risk of cancer. Children with 4 or more major birth defects were 5.9 (95% CI, 5.3-6.4) times more likely to be diagnosed with cancer compared with those without a birth defect. In the analysis of 72 specific BD-CC patterns, 40 HRs were statistically significant (adjusted P <.05) after accounting for multiple comparisons. Cancers most frequently associated with nonchromosomal defects were hepatoblastoma and neuroblastoma. Conclusions and Relevance: Several significant and novel associations were observed between specific birth defects and cancers. Among children with nonchromosomal birth defects, the number of major birth defects diagnosed was significantly and directly associated with cancer risk. These findings could inform clinical treatment for children with birth defects and may elucidate mechanisms that lead to these complex outcomes.

AB - Importance: Birth defects affect approximately 1 in 33 children. Some birth defects are known to be strongly associated with childhood cancer (eg, trisomy 21 and acute leukemia). However, comprehensive evaluations of childhood cancer risk in those with birth defects have been limited in previous studies by insufficient sample sizes. Objectives: To identify specific birth defect-childhood cancer (BD-CC) associations and characterize cancer risk in children by increasing number of nonchromosomal birth defects. Design, Setting, and Participants: This multistate, population-based registry linkage study pooled statewide data on births, birth defects, and cancer from Texas, Arkansas, Michigan, and North Carolina on 10181074 children born from January 1, 1992, to December 31, 2013. Children were followed up to 18 years of age for a diagnosis of cancer. Data were retrieved between September 26, 2016, and September 21, 2017, and data analysis was performed from September 2, 2017, to March 21, 2019. Exposures: Birth defects diagnoses (chromosomal anomalies and nonchromosomal birth defects) recorded by statewide, population-based birth defects registries. Main Outcomes and Measures: Cancer diagnosis before age 18 years, as recorded in state cancer registries. Cox regression models were used to generate hazard ratios (HRs) and 95% CIs to evaluate BD-CC associations and the association between number of nonchromosomal defects and cancer risk. Results: Compared with children without any birth defects, children with chromosomal anomalies were 11.6 (95% CI, 10.4-12.9) times more likely to be diagnosed with cancer, whereas children with nonchromosomal birth defects were 2.5 (95% CI, 2.4-2.6) times more likely to be diagnosed with cancer before 18 years of age. An increasing number of nonchromosomal birth defects was associated with a corresponding increase in the risk of cancer. Children with 4 or more major birth defects were 5.9 (95% CI, 5.3-6.4) times more likely to be diagnosed with cancer compared with those without a birth defect. In the analysis of 72 specific BD-CC patterns, 40 HRs were statistically significant (adjusted P <.05) after accounting for multiple comparisons. Cancers most frequently associated with nonchromosomal defects were hepatoblastoma and neuroblastoma. Conclusions and Relevance: Several significant and novel associations were observed between specific birth defects and cancers. Among children with nonchromosomal birth defects, the number of major birth defects diagnosed was significantly and directly associated with cancer risk. These findings could inform clinical treatment for children with birth defects and may elucidate mechanisms that lead to these complex outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85067820763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067820763&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2019.1215

DO - 10.1001/jamaoncol.2019.1215

M3 - Article

C2 - 31219523

AN - SCOPUS:85067820763

VL - 5

SP - 1150

EP - 1158

JO - JAMA oncology

JF - JAMA oncology

SN - 2374-2437

IS - 8

ER -